JPH07503960A - 安定化放射性医薬品キット - Google Patents

安定化放射性医薬品キット

Info

Publication number
JPH07503960A
JPH07503960A JP5514270A JP51427093A JPH07503960A JP H07503960 A JPH07503960 A JP H07503960A JP 5514270 A JP5514270 A JP 5514270A JP 51427093 A JP51427093 A JP 51427093A JP H07503960 A JPH07503960 A JP H07503960A
Authority
JP
Japan
Prior art keywords
cyclodextrin
phosphine
ligand
kit
radiopharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5514270A
Other languages
English (en)
Japanese (ja)
Inventor
デロッシュ、マーク・エー
ドイッチュ、エドワード・エー
ディツレウスキィ、メアリー・マーミオン
ノスコ、デニス・エル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of JPH07503960A publication Critical patent/JPH07503960A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP5514270A 1992-02-14 1993-02-09 安定化放射性医薬品キット Pending JPH07503960A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/836,644 US5300280A (en) 1992-02-14 1992-02-14 Stabilized radiopharmaceutical kits
US836,644 1992-02-14
PCT/US1993/001196 WO1993015765A1 (en) 1992-02-14 1993-02-09 Stabilized radiopharmaceutical kits

Publications (1)

Publication Number Publication Date
JPH07503960A true JPH07503960A (ja) 1995-04-27

Family

ID=25272404

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5514270A Pending JPH07503960A (ja) 1992-02-14 1993-02-09 安定化放射性医薬品キット

Country Status (15)

Country Link
US (2) US5300280A (enExample)
EP (2) EP1690552A3 (enExample)
JP (1) JPH07503960A (enExample)
AT (1) ATE378073T1 (enExample)
AU (1) AU3662493A (enExample)
BG (1) BG98971A (enExample)
CA (1) CA2129755C (enExample)
DE (1) DE69334183T2 (enExample)
FI (1) FI943724A0 (enExample)
HU (1) HUT74566A (enExample)
IL (1) IL104655A (enExample)
NO (1) NO942899L (enExample)
SK (1) SK96694A3 (enExample)
WO (1) WO1993015765A1 (enExample)
ZA (1) ZA93949B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003505433A (ja) * 1999-07-28 2003-02-12 ブラッコ ダイアグノスティクス，インコーポレイティド テクネチウムＴｃ９９ｍテボロキシム心筋灌流剤の調製のためのキット
JP2022553266A (ja) * 2019-10-21 2022-12-22 ジーイー・ヘルスケア・リミテッド 放射線安定剤としてのシクロデキストリンの使用
JP2024518319A (ja) * 2021-04-26 2024-05-01 ジーイー・ヘルスケア・リミテッド 分析用ｈｐｌｃ

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
CA2158249A1 (en) * 1993-03-31 1994-10-13 James W. Brodack Radiopharmaceutical formulations having non-stannous reductants
US5911970A (en) * 1993-05-06 1999-06-15 Research Corporation Technologies, Inc. Methods for cancer imaging and therapy using benzamine compounds
US6517811B2 (en) 1993-05-06 2003-02-11 Research Corporation Technologies, Inc. Compounds for cancer imaging and therapy
US5993777A (en) * 1993-05-06 1999-11-30 Research Corporation Technologies, Inc. Benzamide compounds for cancer imaging and therapy
US5951964A (en) * 1993-06-04 1999-09-14 Diatide, Inc. Technetium-99m labeled peptides for imaging
FR2726765B1 (fr) * 1994-11-14 1996-12-20 Cis Bio Int Compositions radiopharmaceutiques comprenant un complexe d'inclusion d'une cyclodextrine et d'un acide gras radiohalogene
US5762903A (en) * 1995-03-10 1998-06-09 Korea Atomic Energy Research Institute Radioactive chitosan complex for radiation therapy
ES2243994T5 (es) 1996-04-19 2009-10-29 Grifols Inc. Procedimiento para la inactivacion virica de proteinas de la sangre liofilizadas.
IT1289660B1 (it) * 1996-10-03 1998-10-16 Sorin Biomedica Diagnost Spa Procedimento per la riduzione di composti ossigenati del renio o del tecnezio
WO1998029139A1 (fr) * 1996-12-25 1998-07-09 Gosudarstvenny Nauchny Tsentr Fiziko-Energetichesky Institut PREPARATION CONTENANT UN COMPOSE ORGANIQUE MARQUE A L'AIDE D'UN RADIONUCLEIDE $g(b)
US6905668B1 (en) * 1998-09-25 2005-06-14 Tokyo Gas Company Limited Diagnostic agents for pancreatic exocrine function
NZ337946A (en) * 1998-09-25 2001-11-30 Tokyo Gas Co Ltd C-13 labelled oligosaccharides and polysaccharides useful as diagnostic agents for pancreatic exocrine function
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
WO2006009894A1 (en) * 2004-06-17 2006-01-26 Anazaohealth Corporation Stabilized and lyophilized radiopharmaceutical agents for destroying tumors
US7229603B2 (en) * 2004-06-17 2007-06-12 Anazaohealth Corporation Stablilized and lyophilized radiopharmaceutical agents
US20070189965A1 (en) * 2004-06-17 2007-08-16 Kuperus John H Copper-complex isonitrile positron emission tomography (pet) imaging agent and method
GB0427392D0 (en) * 2004-12-15 2005-01-19 Amersham Plc Stabilised 99mTc compositions
US9321095B2 (en) 2010-06-30 2016-04-26 General Electric Company Apparatuses and methods for cutting porous substrates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219270A (ja) * 1983-05-30 1984-12-10 Wako Pure Chem Ind Ltd テトラゾリウム塩を含有する溶液の安定化方法
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
JPH064770B2 (ja) * 1984-07-31 1994-01-19 三菱電機株式会社 ジチオラト錯体−シクロデキストリン包接化合物の製造方法
ES8801168A1 (es) * 1984-11-02 1987-02-16 Johnson Matthey Plc Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US4714605A (en) * 1986-10-14 1987-12-22 E. R. Squibb & Sons, Inc. Technetium-99m labeled dioxime complexes
US4871836A (en) * 1987-10-13 1989-10-03 E. R. Squibb & Sons, Inc. Boronic acid adducts of rhenium and radioactive isotopes of rhenium dioxime complexes
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
CA1321192C (en) * 1988-04-20 1993-08-10 Abdul Majid Inclusion complexes of cyclodextrins by agglomeration
US5002754A (en) * 1988-06-15 1991-03-26 University Of Cincinnati Technetium (III/II) imaging agents
US5068227A (en) * 1989-01-18 1991-11-26 Cyclex, Inc. Cyclodextrins as carriers
US4917879A (en) * 1989-05-19 1990-04-17 University Of Cincinnati 99MTC(III) myocardial imaging agents that are effective in humans
US5080884A (en) * 1989-12-12 1992-01-14 Medi-Physics, Inc. Hydrocarbylphenyl diaminodithiol radionuclide complexes and their use in imaging
US5026913A (en) * 1989-12-12 1991-06-25 Medi-Physics, Inc. Hydrocarbylphenyl diaminodithiol derivatives
US5183653A (en) * 1990-04-13 1993-02-02 E. R. Squibb & Sons, Inc. Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
US5112595A (en) * 1990-12-21 1992-05-12 Mallinckrodt Medical, Inc. 99MTC(III) myocardial imaging agents and method of use

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003505433A (ja) * 1999-07-28 2003-02-12 ブラッコ ダイアグノスティクス，インコーポレイティド テクネチウムＴｃ９９ｍテボロキシム心筋灌流剤の調製のためのキット
JP2022553266A (ja) * 2019-10-21 2022-12-22 ジーイー・ヘルスケア・リミテッド 放射線安定剤としてのシクロデキストリンの使用
US12527884B2 (en) 2019-10-21 2026-01-20 Ge Healthcare Limited Use of cyclodextrins as a radiostabilizer
JP2024518319A (ja) * 2021-04-26 2024-05-01 ジーイー・ヘルスケア・リミテッド 分析用ｈｐｌｃ

Also Published As

Publication number Publication date
SK96694A3 (en) 1995-03-08
ZA93949B (en) 1993-12-07
CA2129755A1 (en) 1993-08-15
EP0625054A4 (en) 1996-04-17
DE69334183T2 (de) 2008-11-06
US5300280A (en) 1994-04-05
WO1993015765A1 (en) 1993-08-19
EP1690552A2 (en) 2006-08-16
NO942899L (no) 1994-08-04
AU3662493A (en) 1993-09-03
US6428768B1 (en) 2002-08-06
IL104655A0 (en) 1993-06-10
FI943724L (fi) 1994-08-12
DE69334183D1 (de) 2007-12-27
EP1690552A3 (en) 2008-07-02
BG98971A (bg) 1995-06-30
EP0625054A1 (en) 1994-11-23
EP0625054B1 (en) 2007-11-14
FI943724A7 (fi) 1994-08-12
FI943724A0 (fi) 1994-08-12
HUT74566A (en) 1997-01-28
NO942899D0 (enExample) 1994-08-04
ATE378073T1 (de) 2007-11-15
IL104655A (en) 1998-06-15
CA2129755C (en) 2006-01-03
HU9402349D0 (en) 1994-10-28

Similar Documents

Publication Publication Date Title
JPH07503960A (ja) 安定化放射性医薬品キット
US5219556A (en) Stabilized therapeutic radiopharmaceutical complexes
JPH06510539A (ja) 放射性標識ペプチドおよびタンパク質の自己放射線分解を防止する安定剤
JPS58177949A (ja) ランカシジン群抗生物質包接化合物
CA2763365A1 (en) Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
WO2025051302A2 (zh) 一种99mTc注射液制剂及其制备方法
JPH11240833A (ja) ドロロキシフェン医薬組成物
CN101541324B (zh) 医药组合物
EP1307239B1 (en) Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex
US4042677A (en) Technetium-99m labeled radiodiagnostic agents and method of preparation
JP4105435B2 (ja) 放射性医薬剤用の改良型コンテナ構成物
Mardirossian et al. The stability of 99Tcm directly labelled to an Fab'antibody via stannous ion and mercaptoethanol reduction
US6127530A (en) Method for the reduction of oxygenated compounds of rhenium or technetium
US5993776A (en) Radiopharmaceutical compositions that include an inclusion complex of a cyclodextrin and a radio-halogenated fatty acid
JP3568957B2 (ja) 改善された医薬特性を示すエストラムスチン処方物
JPH0546360B2 (enExample)
Péan et al. NMR investigations of the inclusion of thyroxine and derivatives in natural cyclodextrins
WO2025081920A1 (zh) 一种芬戈莫德口服液体组合物及其应用
Riou et al. Differential effects of cyclodextrins and derivatives on the biological behavior of the myocardial perfusion imaging agent 99mTcN-NOET
JP4637096B2 (ja) 放射性組成物及び放射性組成物の製造方法
Goomer et al. Synthesis and evaluation of technetium-99m monocationic mixed ligand complexes of phenyl substituted/condensed tetradentate Schiff's bases and trimethylphosphine
JPS6133127A (ja) 医薬活性化合物の包接化方法
HK1234329A1 (en) Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same

Legal Events

Date Code Title Description
A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20040127

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20040315

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040422

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070220